Compliance Rate

Compliance Rate 42.86%
Compliant submissions 3
Incompliant submissions 4
Total trials 7

My Organizations' Clinical Trials

Showing 875 of 2008 entries
View as:

Transplantation for Patients With Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00186303 Org: User:
Start: 11/30/96 End: 03/31/10 Due: 03/31/11

Recovery of Ventilation After General Anesthesia in Morbidly Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT03925610 Org: User:
Start: 04/10/19 End: 03/30/20 Due: 03/30/21

Evaluating Parent Delivered Interventions for Children With Autism

Phase: N/A Priority: Normal
NCT ID: NCT01882153 Org: User:
Start: 02/28/10 End: 02/18/22 Due: 02/18/23

Transciptomic Modification Induced by miRNAs in Endometrial Fluid

Phase: N/A Priority: Normal
NCT ID: NCT02554539 Org: User:
Start: 07/01/15 End: 07/01/17 Due: 07/01/18

Telehealth-Enabled Versus In-Person Parent-Mediated Behavioral Treatment for Challenging Behaviors in Children With ASD

Phase: N/A Priority: Normal
NCT ID: NCT05268796 Org: User:
Start: 01/05/24 End: 06/30/26 Due: 06/30/27

Steroids After Laser Trabeculoplasty for Glaucoma

Phase: N/A Priority: Normal
NCT ID: NCT00981435 Org: User:
Start: 09/30/09 End: 09/30/15 Due: 09/30/16

Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages

Phase: N/A Priority: Normal
NCT ID: NCT03424226 Org: User:
Start: 08/04/18 End: 09/30/18 Due: 09/30/19

Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT

Phase: N/A Priority: Normal
NCT ID: NCT01144754 Org: User:
Start: 02/28/09 End: 04/30/12 Due: 04/30/13

Effectiveness of a Developmental Reciprocity Treatment Program in Autism

Phase: N/A Priority: Normal
NCT ID: NCT03131635 Org: User:
Start: 07/26/17 End: 07/16/20 Due: 07/16/21

Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

Phase: N/A Priority: Normal
NCT ID: NCT00533572 Org: User:
Start: 08/31/07 End: 08/31/08 Due: 08/31/09

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

Phase: N/A Priority: Normal
NCT ID: NCT01716169 Org: User:
Start: 10/31/12 End: 11/30/13 Due: 11/30/14

Comparison of the Cognitive and Behavioral Effects of Eslicarbazepine Acetate and Carbamazepine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02912364 Org: User:
Start: 07/31/16 End: 04/20/18 Due: 04/20/19

Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the Congo

Phase: N/A Priority: Normal
NCT ID: NCT05107479 Org: User:
Start: 11/09/21 End: 02/10/22 Due: 02/10/23

Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression

Phase: N/A Priority: Normal
NCT ID: NCT00186498 Org: User:
Start: 02/29/04 End: 02/29/08 Due: 02/28/09

Understanding the Impact of Neighborhood Type on Physical Activity in Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT00094211 Org: User:
Start: 09/30/04 End: 06/30/09 Due: 06/30/10

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Phase: N/A Priority: Normal
NCT ID: NCT00627991 Org: User:
Start: 08/31/07 End: - Due: -

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03520842 Org: User:
Start: 08/14/18 End: 06/15/22 Due: 06/15/23

Engaging Patients to Help Achieve Increased Patient Choice and Engagement for AFib Stroke Prevention

Phase: N/A Priority: Normal
NCT ID: NCT04096781 Org: User:
Start: 12/18/19 End: 08/17/22 Due: 08/17/23

Cancer Biology of Retinoblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01642823 Org: User:
Start: 07/31/12 End: 12/31/15 Due: 12/31/16

Oral Camostat Compared With Standard Supportive Care in Mild-Moderate COVID-19 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04524663 Org: User:
Start: 12/19/20 End: 05/15/21 Due: 05/15/22

Integrative Personal Omics Profiling for Dynamic Molecular Phenotypes Monitoring During Fiber Supplementation

Phase: N/A Priority: Normal
NCT ID: NCT04706858 Org: User:
Start: 10/15/14 End: 08/11/17 Due: 08/11/18

Investigation of Mechanisms of Action in Superpower Glass

Phase: N/A Priority: Normal
NCT ID: NCT04049981 Org: User:
Start: 09/04/19 End: 07/01/20 Due: 07/01/21

Compassion Training and Pain

Phase: N/A Priority: Normal
NCT ID: NCT01776645 Org: User:
Start: 01/31/13 End: 05/31/13 Due: 05/31/14

Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label

Phase: N/A Priority: Normal
NCT ID: NCT05494398 Org: User:
Start: 03/12/24 End: 09/30/28 Due: 09/30/29

Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform

Phase: N/A Priority: Normal
NCT ID: NCT01120639 Org: User:
Start: 04/30/10 End: 11/15/20 Due: 11/15/21